Aptorum Group Limited (APM)
NASDAQ: APM · Real-Time Price · USD
1.130
-0.011 (-0.96%)
At close: Dec 19, 2025, 4:00 PM EST
1.130
0.00 (0.01%)
After-hours: Dec 19, 2025, 5:12 PM EST
Aptorum Group Revenue
Aptorum Group had revenue of $199.76K in the half year ending August 31, 2025.
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
1
Market Cap
9.20M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 431.38K | -864.51K | -66.71% |
| Dec 31, 2022 | 1.30M | -245.89K | -15.95% |
| Dec 31, 2021 | 1.54M | 630.27K | 69.15% |
| Dec 31, 2020 | 911.51K | 376.34K | 70.32% |
| Dec 31, 2019 | 535.17K | 151.72K | 39.57% |
| Dec 31, 2018 | 383.45K | - | - |
| Dec 31, 2016 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
APM News
- 4 weeks ago - DiamiR Biosciences and Aptorum Group Announce Two Abstracts Accepted for Presentation at the Clinical Trials on Alzheimer's Disease (CTAD) 2025 Conference - GlobeNewsWire
- 5 weeks ago - Andean Precious Metals Corp. (APM:CA) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Aptorum Group Limited Announces Up To $6 Million Registered Direct Offering - GlobeNewsWire
- 2 months ago - As part of the planned merger with DiamiR Biosciences, Aptorum Group will expand its board and management team with seasoned executives - GlobeNewsWire
- 3 months ago - Aptorum Group and DiamiR Biosciences to Present at the H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewsWire
- 4 months ago - Why Is Nano-Cap Aptorum Stock Rallying On Thursday? - Benzinga
- 4 months ago - DiamiR Biosciences and Aptorum Group Announce New York State Approval for DiamiR's APOE Genotyping Test - GlobeNewsWire
- 4 months ago - Andean Precious Metals Corp. (ANPMF) Q2 2025 Earnings Call Transcript - Seeking Alpha